Sponsored Links

 

Displaying saxagliptin PowerPoint Presentations



Saxagliptin Assessment of Vascular Outcomes Recorded in ... PPT

Presentation Summary : Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) – TIMI 53. Deepak L. Bhatt, MD, MPHOn behalf of the SAVOR-TIMI 53 ...

Source : http://www.cardiosource.org/~/media/Files/Science%20and%20Quality/Clinical%20Trials/ESC%2013%20Slides/SAVOR-TIMI%2053%20Presentation%20Slides.ashx

Type 2 Diabetes Management Goals - AACE - outpatient.aace.com PPT

Presentation Summary : CDC. National diabetes fact sheet, ... Reduce dosage for saxagliptin and sitagliptin ifCrCl <50 mg/dL. Dopamine-2 agonist. Bromocriptine. Use with caution. Glinides.

Source : http://outpatient.aace.com/sites/all/files/T2DM-S4-Management-Goals.pptx

Saxagliptin Assessment of Vascular Outcomes Recorded in ... PPT

Presentation Summary : Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) – TIMI 53 Last modified by: Bhatt, Deepak L.,M.D.,M.P.H.

Source : http://cardiometabolic.cardiosource.org/~/media/CardioMetabolic/Images/HTOct13_SAVOR_Slide2.ashx

Glycemic Management in Type 2 Diabetes - outpatient.aace.com PPT

Presentation Summary : Diabetes Obes Metab. 2007;9:194-205. 2. Goldstein BJ, et al. Diabetes Care ... Weight Changes With Saxagliptin: Mono and Combination Therapy. Monotherapy. 24 Weeks. 1.

Source : http://outpatient.aace.com/sites/all/files/T2DM-S5-New-Antidiabetic-Therapies-050613.pptx

American Diabetes Association - DiabetesPro - Home - American ... PPT

Presentation Summary : standards of medical care in diabetes—2012

Source : http://professional.diabetes.org/SlideLibrary/media/4839/ADA%20Standards%20of%20Medical%20Care%202012%20FINAL.ppt

Incretin Based Therapy of Type 2 Diabetes Mellitus PPT

Presentation Summary : Incretin Based Therapy of Type 2 Diabetes Mellitus BY Prof. ADEL A EL ... Some members seem particularly interesting as saxagliptin (? potent) and alogliptin (long ...

Source : http://www.bibalex.org/diabetessupercourse/DiabetesPPTLectures/Copy%20of%20Incretin%20Based%20Therapy%20of%20Type%202%20Diabetes%20Mellitus_1.ppt

Treatment of DM T-2: Then and Now PPT

Presentation Summary : Saxagliptin (Onglyza) 2.5 – 5 mg/day - FDA-approved July 2009 . Can be used as a monotherapy or in combination with metformin or a glitazone.

Source : http://www.fapaonline.org/files/Kotun--Treatment%20of%20DM%20T-2%20final.pptx

Use of Combination of Saxagliptin/ Dapagliflozin in Patients ... PPT

Presentation Summary : Author: ETreventi Created Date: 08/21/2014 09:44:30 Title: Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin

Source : http://img.medscape.com/images/827/263/827263_slide.pptx

Projects In Knowledge How to Create a PowerPoint Webcast This ... PPT

Presentation Summary : Saxagliptin (n = 8280) Mean age: 65 y Mean HbA1c: ... Meta-analysis GLP-1 receptor agonists 19 studies with exenatide BID, 7 studies with exenatide qwk, ...

Source : http://www.projectsinknowledge.com/Activity/slides/2189_1.ppt

Antidiabetic Medications - UW Courses Web Server PPT

Presentation Summary : ... 100 mg tablets Sitagliptin/metformin (Janumet) 50/500, 50/1000 mg tablets Saxagliptin (Onglyza) 2.5, 5 mg tablets Saxagliptin/metformin (Kombiglyze XR) ...

Source : http://courses.washington.edu/pharm585/Antidiabetic%20Medications.ppt

Now or Never: The Cardiologist’s Role in Improving CV ... PPT

Presentation Summary : ... SAVOR-TIMI 53 SAVOR-TIMI 53: ... Median Fasting Plasma Glucose PowerPoint Presentation Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with ...

Source : http://img.medscape.com/images/812/739/812739_slides.ppt

Slide 1 - Scioto County Medical Society PPT

Presentation Summary : Based on the GLP-1 Pathway Terry W. Sherraden, MD, FACE Tallahassee Endocrine Associates ... and saxagliptin Pharmacologic Agents Exenatide (Exendin-4) ...

Source : http://sciotocountymedicalsociety.org/documents/Current.Therapy.GLP-1.Sherraden.ppt

The Pyramid of Recent Trials - Lipids Online - Educational ... PPT

Presentation Summary : Saxagliptin Monotherapy in Treatment-Naïve Patients with Type 2 Diabetes *P<0.0001 vs PBO BL 4 6 8 12 16 20 24 Weeks Mean ± SE change in A1C from baseline (%) ...

Source : http://lipidsonline.org/ppt_dir/source_ppts/93.ppt

Farr AM, et al. AdvTher. 2014. PPT

Presentation Summary : ... specifically saxagliptin, in treating type 2 diabetes, as adherence and persistence are important to experiencing optimal clinical outcomes. ...

Source : http://static-content.springer.com/esm/art%3A10.1007%2Fs12325-014-0171-3/MediaObjects/12325_2014_171_MOESM1_ESM.pptx

No Slide Title PPT

Presentation Summary : Saxagliptin n/a n/a Ofatumumab rapidly metabolized by hydrolyis of ester linkage; carboxylic acid metabolims further metabolized by glucorondination or oxidation

Source : http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/WomensHealthResearch/UCM272709.ppt

TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX PPT

Presentation Summary : ... * Sitagliptin and saxagliptin have similar A1c lowering effect when used as monotherapy ~0.4-0.79% Saxagliptin/metformin FDC provides a 2.5% decrease in A1c ...

Source : http://pec.ha.osd.mil/files/WebcastPECSep11.ppt

Statistical Considerations for Implementing the FDA T2DM CV ... PPT

Presentation Summary : Statistical Considerations for Implementing the FDA CV Guidance for T2DM Craig Wilson, PhD ... identified by FDA Saxagliptin Onglyza; DPP-4 inhibitor; ...

Source : http://www.amstat.org/chapters/Northeasternillinois/pastevents/presentations/fall09_Wilson.ppt

Slide 1 PPT

Presentation Summary : Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Source : http://care.diabetesjournals.org/content/suppl/2014/08/22/dc13-2546.DC2/Sept_2014_DC13_2546.ppt

Slide 1 PPT

Presentation Summary : Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a ...

Source : http://www.sagarhospitals.in/Uploads/SectionContent/Case%20Study/Ocean%20OF%20Affection/Onglyza%20CME_endo.ppt

PowerPoint Presentation PPT

Presentation Summary : ... 2008 Dipeptidyl-Peptidase 4 Inhibitors Agent in Class: Sitagliptin, Saxagliptin Mechanism of action: slows the inactivation of incretin hormones ...

Source : http://ocdiabetesconference.org/wp-content/uploads/2010/01/Oral-Agents-for-9-12-talk-revised.ppt

PowerPoint Presentation PPT

Presentation Summary : Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a ...

Source : http://cmcendovellore.org/downloads/oral-hypoglycemic-agents.ppt

TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX PPT

Presentation Summary : TMA DoD Pharmacoeconomic CenterFort Sam Houston, TX. MTF Quarterly Webcast. December 13, 2012. ... Saxagliptin. Onglyza (BMS) 2.5mg, 5mg. 07/31/2009. Saxagliptin ...

Source : http://pec.ha.osd.mil/files/PECwebcast_Dec12.pptx

Sponsored Links

Report a violation: If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com